טוען...
Interferon α/β enhances the cytotoxic response of MEK inhibition in melanoma
Drugs that inhibit the MAPK pathway have therapeutic benefit in melanoma, but responses vary between patients, for reasons that are still largely unknown. Here we aim at explaining this variability using pre- and post-MEK inhibition transcriptional profiles in a panel of melanoma cell-lines. We foun...
שמור ב:
| הוצא לאור ב: | Mol Cell |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355234/ https://ncbi.nlm.nih.gov/pubmed/25684207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2014.12.030 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|